Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

4-Aminopyridine gel speeds up burn wound healing and improves skin regeneration.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

A man with scalp and neck skin issues improved after a year of oral isotretinoin.

The optimized Cinchonine gel effectively fights acne bacteria and is safe for twice-daily use.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Clascoterone and minocycline are effective acne treatments with quick results and fewer side effects.

The minoxidil emulgel is feasible and may be more effective for treating male pattern baldness.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Plasma gel and PRP treatments improve skin and hair with minimal side effects.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

The β-sitosterol hair gel is effective and promising for treating hair loss.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

The 810-nm diode laser improves skin texture in keratosis pilaris but not redness.

The non-cross-linked hyaluronic acid compound effectively and safely improves keratosis pilaris.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

The new gel improves treatment of tough skin infections.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.